Home Compare EXAS vs INSM
Stock Comparison · Structural lead, mixed market

Exact Sciences vs Insmed: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Insmed carrying a narrow edge on valuation. Exact Sciences still has the edge on valuation, which keeps the comparison from looking entirely one-sided. The market setup is broadly comparable for both — no clear directional signal from price behavior. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Valuation points more clearly toward Exact Sciences Corp, even if the broader score still leans toward Insmed Incorporated.

Trajectory Similarity
0.71
Similar
Peer-set rank: #7
within Exact Sciences Corp's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

The pair sits on a clearly comparable long-term path, though it is not a near-twin match.

The clearest structural overlap shows up in capital structure and margin trend.

Similarity drivers
capital structuremargin trend
What reduces the match
operating margin level
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EXAS
Exact Sciences Corp
33
Peer-Score
Signal qualityHigh
vs
INSM
Insmed Incorporated
37
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: EXAS vs INSM Profitability 3 20 Stability 30 44 Valuation 33 8 Growth 83 100 EXAS INSM
Gap Ranking
#1 Valuation +25
#2 Growth +17
#3 Profitability +17
#4 Stability +14
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EXAS and INSM Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EXASINSM Relative valuation Structural strength

Insmed Incorporated occupies the cheaper side of the setup map, although Exact Sciences Corp still holds the stronger structural profile.

Valuation position uses Forward P/E where available.

Relative Position vs Comparable Companies
Valuation
Both sit in the weaker half on valuation, with Exact Sciences Corp still coming out ahead.
Growth
Both sit in the stronger range on growth, with Exact Sciences Corp holding the higher position.
Valuation — Dominant Gap
EXAS
33
INSM
8
Gap+25in favour of EXAS

The main spread comes from a meaningfully cheaper peer-relative valuation.

What else supports the lead

Growth adds another layer to the lead, with a very wide gap in revenue growth between the two companies.

What this means for the comparison

The lead is built on both valuation and growth — though valuation still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the EXAS vs INSM comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how EXAS and INSM each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.